SEC Form 4 · accession 0001354488-15-004188
Midatech Pharma US Inc. · DARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul John Richardson
Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 2, 2015 · 3:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000919745
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.86 | Sep 1, 2015 | A | 10,901 | A | — | Sep 1, 2025 | Common Stock | 10,901 | 10,901 | D |
Explanation of responses
- F1This option was granted on September 1, 2015 and vests on November 15, 2015.